Explained: Covid-19 nasal vaccine available now, know how it works and who can take
The nasal vaccine can be administered as a heterologous booster dose by people who have already received Covishield and Covaxin. The government has added the intranasal vaccine Incovacc from Bharat Biotech to its vaccination programme as a mix-and-match, or heterologous, booster dosage, ramping up its anti-Covid actions in response to an increase in cases in other nations, primarily China. The first intranasal vaccination in the world to be authorised for use as a booster dose is Incovacc. “The government of India has approved the nasal vaccine. It will be used as a heterologous booster and will be available first in private hospitals. It will be included in the Covid vaccination program from today,” official sources said earlier in the day. The intranasal vaccine will be India's first such booster dosage because it is unnecessary. It can be given to anyone who is older than 18 years old. The vaccination, which is administered through the nose without the use of a n...